Cargando…

Genome‐wide based model predicting recovery from portosystemic shunting after liver shunt attenuation in dogs

BACKGROUND: In dogs with congenital portosystemic shunt (CPSS), recovery after surgical CPSS attenuation is difficult to predict. OBJECTIVES: Our aim was to build a model with plasma albumin concentration and mRNA expression levels of hepatic gene products as predictors of recovery from portosystemi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van den Bossche, Lindsay, van Steenbeek, Frank G., Weber, Maarten F., Spee, Bart, Penning, Louis C., van Sluijs, Freek J., Zomerdijk, Flin, Groot Koerkamp, Marian J. A., Rothuizen, Jan, Burgener, Iwan A., Kummeling, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060332/ https://www.ncbi.nlm.nih.gov/pubmed/29770973 http://dx.doi.org/10.1111/jvim.15140

Ejemplares similares

Aberrant Gene Expression in Dogs with Portosystemic Shunts
por: van Steenbeek, Frank G., et al.
Publicado: (2013)

Efficacy of orally administered sodium benzoate and sodium phenylbutyrate in dogs with congenital portosystemic shunts
por: van Straten, Giora, et al.
Publicado: (2019)

Correction: Aberrant Gene Expression in Dogs with Portosystemic Shunts
por: van Steenbeek, Frank G., et al.
Publicado: (2013)

Prediction of outcome after ligation or thin film banding of extrahepatic shunts, based on plasma albumin concentration and hematologic expression of 8 target genes in 85 dogs
por: van Blokland‐Post, Krista, et al.
Publicado: (2023)

Distribution of extrahepatic congenital portosystemic shunt morphology in predisposed dog breeds
por: Van den Bossche, Lindsay, et al.
Publicado: (2012)

Aberrant hepatic lipid storage and metabolism in canine portosystemic shunts
por: Van den Bossche, Lindsay, et al.
Publicado: (2017)

Aberrant Expression and Distribution of Enzymes of the Urea Cycle and Other Ammonia Metabolizing Pathways in Dogs with Congenital Portosystemic Shunts
por: van Straten, Giora, et al.
Publicado: (2014)

Evaluation of serum lidocaine/monoethylglycylxylidide concentration to assess shunt closure in dogs with extrahepatic portosystemic shunts
por: Devriendt, Nausikaa, et al.
Publicado: (2021)

Repeated specific canine pancreatic lipase measurements do not identify multiple acquired portosystemic shunts in dogs after extrahepatic portosystemic shunt attenuation
por: Serrano, Gonçalo, et al.
Publicado: (2023)

Treatment of congenital extrahepatic portosystemic shunts in dogs: A systematic review and meta‐analysis
por: Serrano, Gonçalo, et al.
Publicado: (2019)

Sensitivity and Specificity of Plasma ALT, ALP, and Bile Acids for Hepatitis in Labrador Retrievers
por: Dirksen, K., et al.
Publicado: (2017)

Plasma amino acid profiles in dogs with closed extrahepatic portosystemic shunts are only partially improved 3 months after successful gradual attenuation
por: Devriendt, Nausikaa, et al.
Publicado: (2021)

Regenerative and fibrotic pathways in canine hepatic portosystemic shunt and portal vein hypoplasia, new models for clinical hepatocyte growth factor treatment
por: Spee, Bart, et al.
Publicado: (2005)

Complications and outcome of cats with congenital extrahepatic portosystemic shunts treated with thin film: Thirty‐four cases (2008‐2017)
por: Valiente, Paula, et al.
Publicado: (2019)

Comparison of diet, lactulose, and metronidazole combinations in the control of pre‐surgical clinical signs in dogs with congenital extrahepatic portosystemic shunts
por: Serrano, Goncalo, et al.
Publicado: (2022)

Portovenography Findings Following Partial Polypropylene Versus Thin Film Band Attenuation of a Single Congenital Extrahepatic Portosystemic Shunt: A Prospective Randomized Study in Dogs
por: Lipscomb, Victoria, et al.
Publicado: (2023)

Inherited liver shunts in dogs elucidate pathways regulating embryonic development and clinical disorders of the portal vein
por: van Steenbeek, Frank G., et al.
Publicado: (2011)

Use of Serum MicroRNAs as Biomarker for Hepatobiliary Diseases in Dogs
por: Dirksen, K., et al.
Publicado: (2016)

Complications associated with ventriculoperitoneal shunts in dogs and cats with idiopathic hydrocephalus: A systematic review
por: Gradner, Gabriele, et al.
Publicado: (2019)

Palliative ventriculoperitoneal shunting in dogs with obstructive hydrocephalus caused by tumors affecting the third ventricle
por: Orlandi, Rocio, et al.
Publicado: (2020)

Clinical features and outcome of dogs and cats with bidirectional and continuous right‐to‐left shunting patent ductus arteriosus
por: Greet, Victoria, et al.
Publicado: (2021)

Association of circulating microRNA‐122 and microRNA‐29a with stage of fibrosis and progression of chronic hepatitis in Labrador Retrievers
por: Sakai, Manabu, et al.
Publicado: (2018)

Gene expression patterns in the progression of canine copper-associated chronic hepatitis
por: Dirksen, Karen, et al.
Publicado: (2017)

Association between improvement of clinical signs and decrease of ventricular volume after ventriculoperitoneal shunting in dogs with internal hydrocephalus
por: Schmidt, Martin J., et al.
Publicado: (2019)

Prevalence of seizures in dogs and cats with idiopathic internal hydrocephalus and seizure prevalence after implantation of a ventriculo‐peritoneal shunt
por: Farke, Daniela, et al.
Publicado: (2020)

Solitary intraventricular tumors in dogs and cats treated with radiotherapy alone or combined with ventriculoperitoneal shunts: A retrospective descriptive case series
por: Beckmann, Katrin, et al.
Publicado: (2022)

Risk factors, treatment, and outcome in dogs and cats with subdural hematoma and hemispheric collapse after ventriculoperitoneal shunting of congenital internal hydrocephalus
por: Farke, Daniela, et al.
Publicado: (2023)

Portal Vein/Aorta Ratio in Dogs with Acquired Portosystemic Collaterals
por: Sakamoto, Y., et al.
Publicado: (2017)

Plasma renin activity and aldosterone concentration in dogs with acquired portosystemic collaterals
por: Sakamoto, Yumi, et al.
Publicado: (2019)

Identification of potential drugs for treatment of hepatic lipidosis in cats using an in vitro feline liver organoid system
por: Haaker, Maya W., et al.
Publicado: (2019)

Outcome of non-surgical dietary treatment with or without lactulose in dogs with congenital portosystemic shunts
por: Favier, Robert P., et al.
Publicado: (2020)

Congenital portosystemic venous shunt
por: Papamichail, M., et al.
Publicado: (2017)

Parallel Shunt for the Treatment of Transjugular Intrahepatic Portosystemic Shunt Dysfunction
por: Luo, Xuefeng, et al.
Publicado: (2013)

Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020
por: Horhat, Adelina, et al.
Publicado: (2021)

Prevalence and characterization of hypoadrenocorticism in dogs with signs of chronic gastrointestinal disease: A multicenter study
por: Hauck, Christina, et al.
Publicado: (2020)

The Role of Percutaneous Transjugular Portosystemic Shunts
por: Gordon, Roy L.
Publicado: (1992)

Congenital Portosystemic Shunt: Our Experience
por: Timpanaro, Tiziana, et al.
Publicado: (2015)

Asymptomatic Congenital Intrahepatic Portosystemic Shunt
por: Brown, Karen M., et al.
Publicado: (2016)

Congenital intrahepatic portosystemic venous shunt
por: Kashgari, Amna, et al.
Publicado: (2020)

Presentation of Congenital Portosystemic Shunts in Children
por: Bahadori, Atessa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_js1fqm8uofu15qhgi473dgku79